Menactra is the latest vaccine for meningococcal meningitis
November 2006
Menactra is the latest vaccine for meningococcal meningitis.
Think of Menactra as a new and improved Menomune.
Menomune provides immunity for only 3 to 5 years...Menactra immunity will likely last much longer.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive